Endoscopic endonasal resection of the odontoid process: clinical outcomes in 34 adults

Journal of Neurosurgery
Nathan T ZwagermanPaul A Gardner

Abstract

OBJECTIVE Treatment of odontoid disease from a ventral corridor has consisted of a transoral approach. More recently, the endoscopic endonasal approach (EEA) has been used to access odontoid pathology. METHODS A retrospective review was conducted of patients who underwent an EEA for odontoid pathology from 2004 to 2013. During our analysis, the mean follow-up duration was 42.6 months (range 1-80 months). Patient outcomes, complications, and postoperative swallowing function were assessed either by clinic visit or phone contact. RESULTS Thirty-four patients underwent an EEA for symptomatic odontoid pathology. The most common pathology treated was basilar invagination (n = 17). Other pathologies included odontoid fractures, os odontoideum, and metastatic carcinoma. The mean patient age was 71.5 years. Thirty-one patients underwent a posterior fusion. All 34 patients experienced stability or improvement in symptoms and all had successful radiographic decompression. The overall complication rate was 76%. Nearly all of these complications were transient (86%) and the overall complication rate excluding mild transient dysphagia was only 44%. Twenty-one patients (62%) suffered from transient postoperative dysphagia: 15 cases were mild...Continue Reading

References

Sep 1, 1978·Neurosurgery·M L ApuzzoJ S Heiden
May 1, 1986·The Journal of Bone and Joint Surgery. British Volume·H A CrockardW K Essigman
Jan 1, 1996·Acta neurochirurgica·H D Jho, R L Carrau
Jun 3, 1998·Journal of Neurosurgery·A GoelK Desai
Apr 17, 2002·Acta neurochirurgica·A AlfieriM Tschabitscher
Apr 7, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·L M CavalloM Tschabitscher
May 12, 2007·Neurosurgical Review·Andrea MessinaManfred Tschabitscher
Jun 15, 2007·Infectious Disease Clinics of North America·Mark W Hull, Anthony W Chow
Nov 15, 2007·American Journal of Rhinology·Jayakar V NayakCarl H Snyderman
Feb 12, 2008·Otolaryngologic Clinics of North America·Paul A GardnerRicardo L Carrau
Mar 18, 2008·Arquivos de neuro-psiquiatria·José Alberto LandeiroCarlos Henrique Ribeiro
Apr 5, 2008·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Arnold H Menezes
Jan 28, 2009·The Laryngoscope·John R de AlmeidaAmin B Kassam
Nov 2, 2014·Journal of Neurosurgery·Tony GoldschlagerTheodore H Schwartz

❮ Previous
Next ❯

Citations

Jul 23, 2019·International Forum of Allergy & Rhinology·Eric W WangCarl H Snyderman

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.